ANZHFR 2021 Annual Report
The ANZHFR is very pleased to be able to provide you with the 2021 Annual Report. We would like to express our appreciation to all the people who have been involved in collecting, collating and analysing the data for this report and those who have put in a great effort progressing it to completion. We hope you will find the Annual Report enlightening and useful as you continue in your endeavours to improve the quality of hip fracture care for your patients. The Australian State report is included in both the Clinical Care Standard Report and the Full e-Report, rather than as a separate Supplementary report as in previous years. For the first time, the reports also include an Outlier Report, which monitors hospital performance against the quality indicators and enables sites to easily see areas of high quality care or those that require review. A PowerPoint slide pack has also been provided should you wish to use it. The slides follow the structure of the Clinical Care Standard Report (excluding Australian State Report and they can be customised to highlight your hospital’s performance and add in any other relevant information e.g., additional figures from the full report or other site-specific information. There is included a pull-out text box and pointer for the hospital level charts. These can be moved down the axis, to line up with your hospital. The pointer and text box can also be positioned separately – simply click on the text box if you need to move it whilst leaving the pointer in place. This is useful towards the bottom of each slide. If you want to highlight more than one hospital, the pointer and text box can be copied and pasted
The ANZHFR is very pleased to be able to provide you with the 2021 Annual Report. We would like to express our appreciation to all the people who have been involved in collecting, collating and analysing the data for this report and those who have put in a great effort progressing it to completion. We hope you will find the Annual Report enlightening and useful as you continue in your endeavours to improve the quality of hip fracture care for your patients.
The Australian State report is included in both the Clinical Care Standard Report and the Full e-Report, rather than as a separate Supplementary report as in previous years. For the first time, the reports also include an Outlier Report, which monitors hospital performance against the quality indicators and enables sites to easily see areas of high quality care or those that require review.
A PowerPoint slide pack has also been provided should you wish to use it. The slides follow the structure of the Clinical Care Standard Report (excluding Australian State Report and they can be customised to highlight your hospital’s performance and add in any other relevant information e.g., additional figures from the full report or other site-specific information. There is included a pull-out text box and pointer for the hospital level charts. These can be moved down the axis, to line up with your hospital. The pointer and text box can also be positioned separately – simply click on the text box if you need to move it whilst leaving the pointer in place. This is useful towards the bottom of each slide. If you want to highlight more than one hospital, the pointer and text box can be copied and pasted
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Indicator 6a: Proportion of patients with a hip fracture receiving bone protection medicine
prior to separation from the hospital at which they underwent hip fracture surgery.
The Hip Fracture Care Clinical Care Standard requires an assessment and management plan for future fracture prevention,
including initiation of treatment for osteoporosis in hospital where appropriate. The Registry is able to capture this in the
acute setting but data reported here may underestimate the number of people treated for osteoporosis, particularly in cases
where patients are transferred to another hospital for subacute care.
Figure 16 shows that in New Zealand, 29% of hip fracture patients left hospital on a bisphosphonate, denosumab or
teriparatide, compared with 9% on admission. In Australia, 26% of patients left hospital on a bisphosphonate, denosumab
or teriparatide, compared with 10% on admission. Whilst it’s not always possible to initiate treatment in the acute setting, the
data continues to highlight substantial variation between hospitals and a significant missed opportunity to contribute towards
preventing another fracture. The ANZHFR will conduct a Sprint Audit later in 2021 to examine some of the issues around
bone protection medication in more detail.
ANZHFR / ANNUAL REPORT 2021
45
Change language